Literature DB >> 4740461

Complications from intrathecal steroid therapy in patients wsith multiple sclerosis.

D A Nelson, T S Vates, R B Thomas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4740461     DOI： 10.1111/j.1600-0404.1973.tb01289.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN： 0001-6314            Impact factor:   3.209


× No keyword cloud information.
  10 in total

Review 1.  Intraspinal steroids: history, efficacy, accidentality, and controversy with review of United States Food and Drug Administration reports.

Authors:  D A Nelson; W M Landau
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-04       Impact factor: 10.154

2.  Sclerosing spinal pachymeningitis. A complication of intrathecal administration of Depo-Medrol for multiple sclerosis.

Authors:  J L Bernat; C H Sadowsky; F M Vincent; R E Nordgren; G Margolis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-11       Impact factor: 10.154

3.  Neurology-epitomes of progress: treatment of multiple sclerosis with adrenal cortical steroids.

Authors:  J R Nelson
Journal:  West J Med       Date:  1977-08

Review 4.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

5.  Modifications of the cerebrospinal fluid IgG concentrations in patients with multiple sclerosis treated with intrathecal steroids.

Authors:  A R Massaro
Journal:  J Neurol       Date:  1978-12-22       Impact factor: 4.849

6.  Intrathecal versus systemic corticosteroids in the treatment of multiple sclerosis: results of a pilot study.

Authors:  R Heun; U Sliwka; H Rüttinger; K Schimrigk
Journal:  J Neurol       Date:  1992-01       Impact factor: 4.849

7.  Multiple sclerosis intra-blood-brain-barrier IgG synthesis: effect of pulse intravenous and intrathecal corticosteroids.

Authors:  R W Baumhefner; W W Tourtellotte; K Syndulko; A Staugaitis; P Shapshak
Journal:  Ital J Neurol Sci       Date:  1989-02

Review 8.  Safety of intrathecal route: focus to methylprednisolone acetate (Depo-Medrol) use.

Authors:  Joël Schlatter; David Nguyen; Michèle Zamy; Sofiane Kabiche; Jean-Eudes Fontan; Salvatore Cisternino
Journal:  Eur Spine J       Date:  2017-11-18       Impact factor: 3.134

9.  Repeated intrathecal triamcinolone acetonide administration in progressive multiple sclerosis: a review.

Authors:  Mazen Abu-Mugheisib; Reiner Benecke; Uwe K Zettl
Journal:  Mult Scler Int       Date:  2011-06-26

10.  Polyamidoamine dendrimer-conjugated triamcinolone acetonide attenuates nerve injury-induced spinal cord microglia activation and mechanical allodynia.

Authors:  Hwisung Kim; Boomin Choi; Hyoungsub Lim; Hyunjung Min; Jae Hoon Oh; Sunghyun Choi; Joung Goo Cho; Jong-Sang Park; Sung Joong Lee
Journal:  Mol Pain       Date:  2017-01       Impact factor: 3.395
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.